Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01640 |
| Species: | Homo sapiens |
| Position : | chr12:121803095-121805690 |
| Year: | 2023 |
| Title: | Super Enhancer-Regulated LncRNA LINC01089 Induces Alternative Splicing of DIAPH3 to Drive Hepatocellular Carcinoma Metastasis. |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | hepatocellular carcinoma |
| PMID: | 37756562 |
| MONDO: | MONDO:0007256 |
| Tissue: | liver |
| Tissue Ontology ID: | UBERON:0002107 |
| Cell Source: | SK-HEP-1 |
| CVCL ID: | CVCL_0525 |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay; In vivo functional validation |
| High Throughput Method: | ChIP-seq, ATAC-seq, RNA-seq |
| Low Throughput Method: | Luciferase Reporter Assay, CRISPR Knockout, CRISPRi, RT-RT-qPCR; In vivo phenotyping |
| Target gene : | LINC01089 |
| TF name : | NA |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01639 | chr12:121803095-121805690 | liver | hepatocyte | hepatocellular carcinoma |
| E_01641 | chr12:121803095-121805690 | liver | malignant cell | hepatocellular carcinoma |
| E_01642 | chr12:121803095-121805690 | liver | malignant cell | hepatocellular carcinoma |
| E_01671 | chr12:121803095-121805690 | liver | hepatocyte | hepatocellular carcinoma |
| E_01672 | chr12:121803095-121805690 | liver | malignant cell | hepatocellular carcinoma |
| E_01673 | chr12:121803095-121805690 | liver | malignant cell | hepatocellular carcinoma |